Learn More
Both central and upper-body adiposity are associated with high rates of type II non-insulin-dependent diabetes mellitus (NIDDM), high triglyceride levels, and low high-density lipoprotein (HDL)(More)
BACKGROUND Hispanics are the fastest growing minority group in the United States, and approximately 10% of all end-stage renal disease (ESRD) patients are Hispanic. Few data are available, however,(More)
Mexican Americans have a higher prevalence of NIDDM, more overall obesity and more centralized adiposity than non-Hispanic whites, but have thus far not been characterized as to whether they have(More)
Principal goals of the End-Stage Renal Disease (ESRD) Core Indicators Project are to improve the care provided to ESRD patients and to identify categorical variability in intermediate outcomes of(More)